<?xml version="1.0" encoding="UTF-8"?>
<p>CRISPR/Cas 9-mediated gene mutagenesis was used to knock out Nrp2 in the near-haploid HAP-1 cell line and in human umbilical vein endothelial cells (HUVECs). In both cases, Nrp2 deficiency made the cells almost completely resistant to HCMV infection. </p>
